p53‐repressed miRNAs are involved with E2F in a feed‐forward loop promoting proliferation
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Normal cell growth is governed by a complicated biological system, featuring multiple levels of control, often deregulated in cancers. The role of microRNAs (miRNAs) in the control of gene expression is now increasingly appreciated, yet their involvement in controlling cell proliferation is still not well understood. Here we investigated the mammalian cell proliferation control network consisting of transcriptional regulators, E2F and p53, their targets and a family of 15 miRNAs. Indicative of their significance, expression of these miRNAs is downregulated in senescent cells and in breast cancers harboring wild-type p53. These miRNAs are repressed by p53 in an E2F1-mediated manner. Furthermore, we show that these miRNAs silence antiproliferative genes, which themselves are E2F1 targets. Thus, miRNAs and transcriptional regulators appear to cooperate in the framework of a multi-gene transcriptional and post-transcriptional feed-forward loop. Finally, we show that, similarly to p53 inactivation, overexpression of representative miRNAs promotes proliferation and delays senescence, manifesting the detrimental phenotypic consequence of perturbations in this circuit. Taken together, these findings position miRNAs as novel key players in the mammalian cellular proliferation network.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · cited 2×
“To that end, we infected WI-38 cells with a retrovirus encoding for either an shRNA targeting p53 (p53i) or a control shRNA (con) and treated them with Nutlin-3, a small molecule that stabilizes the p53 protein by inhibiting its Mdm2-dependent ubiquitylation and degradation”
BackgroundMethodCombinatorial microRNA target predictions
Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603 · cited 4×
“We also observed downregulation of p57 in WI-38 cells, in agreement with PicTar predictions (Figure 6A; Supplementary Figure S4).”
BackgroundMethodInfluentialCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 1×
“p53 is a sequence-specific transcription factor (TF) that exerts many of its downstream effects by activating gene transcription”
BackgroundUnique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023 · cited 1×
“…and miR-155, are considered oncogenic miRs and are overexpressed in diverse types of tumors (Eis et al, 2005; He et al, 2005; Volinia et al, 2006; Yanaihara et al, 2006). miR-15b and miR-16, which are considered to be tumor suppressor miRs (Cimmino et al, 2005), are exceptions in this regard.”
BackgroundSelf-citationA microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 2×
“As p53 is capable of inducing senescence in vivo (Xue et al, 2007), the observed miRNA repression in the wild-type p53-harboring breast tumorsmay be associated with increased senescence in these samples.”
BackgroundTransactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010 · cited 2×
“p53-repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation”
BackgroundWhitfield, M. L., Sherlock, G., Saldanha, A. J., Murray, J. I., Ball, C. A., Alexander, K. E., Matese, J. C., Perou, C. M., Hurt, M. M., Brown, P. O., et al. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-02-0030 · Cited by 1,527 · cited 2×
“…Systems Biology 2008 5 cell-cycle-related genes, we compared the mRNA dataset to a previously published list of genes expressed in a cell-cycle periodic manner (Whitfield et al, 2002), and found a significant enrichment of periodically expressed genes in this cluster (Figure 3H; P-value¼4.9 10 17).”
BackgroundResultInfluentialThe Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution
Farh, K. K.-H., Grimson, A., Jan, C., Lewis, B. P., Johnston, W. K., Lim, L. P., Burge, C. B., & Bartel, D. P. (2005) · Science · doi:10.1126/science.1121158 · Cited by 1,484
Cited by
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
“In fact, a number of miRNAs that target antiproliferative genes have been shown to be repressed by p53 in a manner that requires E2F, not unlike other targets of p53-mediated repression (Brosh et al., 2008).”
BackgroundThe first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Self-citationDi Leva, G., Garofalo, M., & Croce, C. M. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104715 · Cited by 1,672
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
“As wild-type p53 can repress the expression of the proliferation signature by inhibiting the activity of E2F1 and NF-”
BackgroundSelf-citationRivlin, N., Brosh, R., Oren, M., & Rotter, V. (2011) · Genes & Cancer · doi:10.1177/1947601911408889 · Cited by 1,033
Self-citationp53 and E2f: partners in life and death
Polager, S., & Ginsberg, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2718 · Cited by 498
“For example, there could be miRs that are co-regulated by E2f and p53, as suggested by a recent study identifying miRs that are repressed by p53 in an E2f-dependent manne”
BackgroundSelf-citationmiR-15 Family Regulates Postnatal Mitotic Arrest of Cardiomyocytes
Porrello, E. R., Johnson, B. A., Aurora, A. B., Simpson, E., Nam, Y.-J., Matkovich, S. J., Dorn, G. W., van Rooij, E., & Olson, E. N. (2011) · Circulation Research · doi:10.1161/circresaha.111.248880 · Cited by 444
Bueno, M. J., & Malumbres, M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.02.002 · Cited by 410
microRNA Expression Patterns Reveal Differential Expression of Target Genes with Age
Noren Hooten, N., Abdelmohsen, K., Gorospe, M., Ejiogu, N., Zonderman, A. B., & Evans, M. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010724 · Cited by 357
Clustered miRNAs and their role in biological functions and diseases
Kabekkodu, S. P., Shukla, V., Varghese, V. K., D' Souza, J., Chakrabarty, S., & Satyamoorthy, K. (2018) · Biological Reviews · doi:10.1111/brv.12428 · Cited by 358
miR‐17, miR‐19b, miR‐20a, and miR‐106a are down‐regulated in human aging
Hackl, M., Brunner, S., Fortschegger, K., Schreiner, C., Micutkova, L., Mück, C., Laschober, G. T., Lepperdinger, G., Sampson, N., Berger, P., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00549.x · Cited by 355
miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
Enerly, E., Steinfeld, I., Kleivi, K., Leivonen, S.-K., Aure, M. R., Russnes, H. G., Rønneberg, J. A., Johnsen, H., Navon, R., Rødland, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016915 · Cited by 310
Self-citationVitamin D Receptor Signaling Mechanisms: Integrated Actions of a Well-Defined Transcription Factor
Carlberg, C., & Campbell, M. J. (2013) · Steroids · doi:10.1016/j.steroids.2012.10.019 · Cited by 293
The hallmarks of fibroblast ageing
Tigges, J., Krutmann, J., Fritsche, E., Haendeler, J., Schaal, H., Fischer, J. W., Kalfalah, F., Reinke, H., Reifenberger, G., Stühler, K., et al. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2014.03.004 · Cited by 250
“proliferative genes and delay replicative senescence, when overexpressed in human embryonic fibroblast cells (Brosh et al., 2008).”
BackgroundAlterations in microRNA expression in stress-induced cellular senescence
Li, G., Luna, C., Qiu, J., Epstein, D. L., & Gonzalez, P. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.09.002 · Cited by 219
Mutant p53 drives invasion in breast tumors through up-regulation of miR-155
Neilsen, P. M., Noll, J. E., Mattiske, S., Bracken, C. P., Gregory, P. A., Schulz, R. B., Lim, S. P., Kumar, R., Suetani, R. J., Goodall, G. J., et al. (2013) · Oncogene · doi:10.1038/onc.2012.305 · Cited by 167
Aylon, Y., & Oren, M. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.002 · Cited by 106
“Current Opinion in Genetics & Development 2011, 21:86–92 A cluster of cancer-associated miRNAs, including miR106b/93/25 and others, is repressed by p53 in an E2F1mediated manner [23 ].”
BackgroundSelf-citationBöhlig, L., Friedrich, M., & Engeland, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq796 · Cited by 85
Huang, Q., Ma, C., Chen, L., Luo, D., Chen, R., & Liang, F. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00370 · Cited by 78
“In addition, somemiRNAs conversely affect translation of TFs (98).”
BackgroundLai, C., Wu, Y., Yu, S., Yu, Y., Lee, S., Liu, C., Hsieh, W., Hwu, H., Chen, P., Jeng, S., et al. (2014) · Aging Cell · doi:10.1111/acel.12225 · Cited by 38
“This inverse correlation of miRNAs with p53 might account for the prevention of tumorigenesis by the downregulation of these miRNAs in adulthood and during aging (Brosh et al., 2008; Elsharawy et al., 2012).”
Metadata
- Authors
- Brosh, R., Shalgi, R., Liran, A., Landan, G., Korotayev, K., Nguyen, G. H., Enerly, E., Johnsen, H., Buganim, Y., Solomon, H., Goldstein, I., Madar, S., Goldfinger, N., Børresen‐Dale, A., Ginsberg, D., Harris, C. C., Pilpel, Y., Oren, M., & Rotter, V.
- Venue
- Molecular Systems Biology
- Published
- 2008-01
- Volume
- 4
- Issue
- 1
- Pages
- 229-229
- ISSN
- 1744-4292 (ISSN-L)
- OpenAlex
- W2157456513
- Cited by
- 152
- References
- 16
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.